Supported by Cytokinetics
The 2021 HFSA Lifetime Achievement Award is now open for nominations!
More information can be found below. Check back soon on the announcement of the 2020 awardee.
Deadline for Submission: August 28, 2020
Award Presentation: 2021 HFSA Annual Scientific Meeting (September 10-13, 2021 | Denver, CO)
Notification to Award Winner: November 2020
Any living individual whose career has focused on heart failure may be nominated. The award will be made on the basis of the recipient’s contributions as follows:
- Advancement of scientific knowledge, either basic or clinical research directly to heart failure
- Improvement in the practice of treating patients with heart failure
- Demonstrated service to the mission of the HFSA
Evaluation of nominees and selection of the recipient will be chosen by a majority vote of the Lifetime Achievement Award Committee and submitted to the HFSA Executive Council for approval.
Each Nomination should consist of:
- A letter of recommendation from a nominator which should highlight the nominees’ career in detail (2 pages maximum)
- Copy of an up-to-date curriculum vitae (including publications)
Nominations may only be made by HFSA members in good standing. Self-nominations will not be accepted.
Previous Winners are not eligible for this Award!
Nominations are carried forward from the previous three years but information submitted may need to be updated and re-submitted. Materials resubmitted should include any significant developments or contributions which have occurred since the previous submission.
Previous HFSA Lifetime Achievement Award
Dr. Douglas L. Mann, MD, FHFSA is the Lewin Chair and Professor of Medicine, Cell Biology and Physiology, Chief of the Division of Cardiology at the Washington University School of Medicine, and Cardiologist in Chief at Barnes Jewish Hospital in St. Louis. He received his medical degree from Temple University School of Medicine in Philadelphia and completed fellowships in clinical cardiology at the University of California San Diego, and Massachusetts General Hospital in Boston.
Dr. Mann’s primary research interest has been the molecular and cellular basis of heart failure, with particular emphasis on the role of innate immunity in disease progression and recovery of the failing heart. He is the author of numerous peer reviewed articles on the role on inflammatory mediators in cardiac remodeling and myocardial recovery. Dr. Mann is also the editor of Heart Failure, A Companion to Braunwald’s Heart Disease, and a co-editor of Braunwald’s Heart Disease, the leading textbook in cardiovascular medicine.
Dr. Mann is the founding editor of JACC: Basic to Translational Science, and is currently serving on the Editorial Board for a number of leading cardiovascular journals.
He is a member of the American Society for Clinical Investigation, the Association of American Physicians, the Association of University Cardiologists, the Heart Failure Society of America and the American Clinical and Climatological Association. He is the past president of the Heart Failure Society of America.
2019 – Dr. Douglas L. Mann, MD, FHFSA
2018 – Marvin A. Konstam, DM, FACC, FAHA, FHFSA
2017 – Barry H. Greenberg, MD, FHFSA
2016 – Marc Pfeffer, MD, PhD, FHFSA
2015 – Sidney Goldstein, MD, FHFSA
2014 – Gary S. Francis, MD, FHFSA
2013 – Arthur M. Feldman, MD, PhD & Barry M. Massie, MD, FHFSA
2012 – Bertram Pitt MD, FHFSA
2011 – Kathy Dracup, PhD, FHFSA
2010 – Eugene Braunwald, MD, FHFSA
2009 – Kanu Chatterjee, MBBS, FRCP
2008 – Michael R. Bristow, MD, PhD, FHFSA
2007 – Arnold M. Katz, MD
2006 – Jay N. Cohn, MD, FHFSA
Lifetime Meritorious Service Award
2014 – Jay N. Cohn, MD, FHFSA
2013 – Barry M. Massie, MD, FHFSA